People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Telos Biotech Inc. | — | Biotechnology | Pre-Seed | $1.4M | $1.4M | 2025 |
| Cyclone Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $800K | $37.8M | 2020 |
Sebastian Aguiar Brunemeier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sebastian Aguiar Brunemeier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James G. Peyer | 1 | 3 |
| Enzo Ehsan Tedone | 1 | 1 |
| Mohammad Ehsan Sayed | 1 | 1 |
| Jerry William Shay | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.